|
[1]
|
国家卫生健康委办公厅, 国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml, 2022-10-01.
|
|
[2]
|
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
宋雅婷, 侯欣, 陆旻雅, 等. 新型冠状病毒血清特异性抗体检测技术应用探讨[J]. 协和医学杂志, 2020, 11(6): 649-653.
|
|
[4]
|
黄悦, 庄春兰, 葛胜祥, 等. 2019年新型冠状病毒血清学检测的临床和公共卫生意义探讨[J]. 病毒学报, 2020, 36(3): 537-540.
|
|
[5]
|
貌盼勇, 朱雷, 王佑春, 等. SARS-CoV特异性抗体产生规律的初步研究[J]. 中华流行病学杂志, 2004, 25(10): 856-858.
|
|
[6]
|
Castro Dopico, X., Ols, S., Loré, K. and Karlsson Hedestam, G.B. (2021) Immunity to SARS-CoV-2 Induced by Infection or Vaccination. Journal of Internal Medicine, 291, 32-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Vadrevu, K.M., Ganneru, B., Reddy, S., Jogdand, H., Raju, D., Sapkal, G., et al. (2022) Persistence of Immunity and Impact of Third Dose of Inactivated COVID-19 Vaccine against Emerging Variants. Scientific Reports, 12, Article No. 12038. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Abufares, H.I., Oyoun Alsoud, L., Alqudah, M.A.Y., Shara, M., Soares, N.C., Alzoubi, K.H., et al. (2022) COVID-19 Vaccines, Effectiveness, and Immune Responses. International Journal of Molecular Sciences, 23, Article 15415. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Takahashi, T. and Iwasaki, A. (2021) Sex differences in immune responses. Science, 371, 347-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
张蕊, 燕忠生, 牛小娟. “乙类乙管”疫情防控政策下甘肃省兰州市中青年人群新冠病毒感染的流行学调查及思考[J]. 中国呼吸与危重监护杂志, 2023, 22(7): 480-485.
|
|
[11]
|
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染的肺炎纳入法定传染病管理的公告[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/44a3b8245e8049d2837a4f27529cd386.shtml, 2022-04-20.
|
|
[12]
|
湖北省人民政府. 湖北省人民政府关于加强新型冠状病毒感染的肺炎防控工作的通告[EB/OL]. https://www.hubei.gov.cn/zfwj/ezf/202002/t20200220_2142431.shtml, 2022-04-20.
|
|
[13]
|
丁哲渊, 吴昊澄, 吴晨, 等. 浙江省新型冠状病毒肺炎疫情应急响应期间其他法定传染病监测分析[J]. 疾病监测, 2020, 35(8): 746-752.
|
|
[14]
|
国家卫生健康委员会. 《关于对新型冠状病毒感染实施“乙类乙管”的总体方案》解读问答[J]. 中国新闻发布(实务版), 2023(1): 21-24.
|